Understanding BRACAnalysis®: Hereditary Cancer Testing
BRACAnalysis® is additionally an essential clinical genetic test that determines the presence of mutations in the high-risk BRCA1 and BRCA2 genes associated with hereditary breast and ovarian cancer syndrome. People with such mutations have up to 87 percent of chances of getting breast cancer and up to 44 percent for ovarian cancer before they are 70 years of age. This relatively simple test can be done by a blood sample, a saliva swab just as well. Gene knowledge can help both you and your doctor to create a healthy minimizing healthcare risks future in the future. When a mutation is identified, measures such as enhanced screening, chemoprevention, and in some cases preventive surgeries may also be useful in managing cancer risks optimally.More so, research in the field has focused on the possible use of preventive measures such as chemoprevention in the prevention of mutation related cancers.
Check out: Bracanalysis hereditary cancer testing
